Duncan Family Institute for Cancer Prevention and Risk Assessment
Jennifer Tektiridis, Ph.D., CPA
Executive Director, Research Planning and Development
Mickie Lubin
Program Director, Office of the Vice President
The Duncan Family Institute for Cancer Prevention and Risk Assessment, formed in 2008 through a generous gift from the Duncan Family, is advancing the science and practice of cancer prevention by accelerating the discovery and translation of new knowledge about cancer risk factors and developing innovative ways to reduce risk and prevent cancer while expanding our studies to attack multiple risk factors using complementary strategies. The Duncan Family Institute serves to foster collaboration aimed at breaking new ground in cancer prevention.
Our Goals
- Discover the roles biologic, genetic, environmental, behavioral and social factors play in cancer development
- Investigate medical and lifestyle interventions to stop cancer development or slow its progression, mindful of their potential applications to later-stage cancers
- Accelerate development and transfer of new tools and evidence-based interventions to the clinic and the community
Seed funding supports the development of preliminary data for innovative research
The Seed Funding Research Program provides financial support to investigators working to generate preliminary data necessary to improve competitiveness for extramural support for larger and inventive hypothesis-driven studies.
Fellowship fills the gap from training positions to junior faculty
The Mentored Junior Faculty Fellowship in Cancer Prevention Research supports the critical transition of individuals from training positions to junior faculty, launching them towards research independence.
Faculty in the News
-
Genetic Engineering & Biotechnology News
Lung Cancer Screening Eligibility Better Predicted by Blood Biomarkers and Smoking History
Samir Hanash, M.D., Ph.D.
-
Inverse
Fiber is Better for Immunity Than Probiotics - Study
Carrie Daniel-MacDougall, Ph.D.
-
ASCO Daily News
ASCO Updates Guidance on Use of Abemaciclib and Endocrine Therapy in Patients With High-Risk Early Breast Cancer
Sharon Giordano, M.D.
-
WebMD
Exercise: A New Breast Cancer 'Drug'?
Karen Basen-Engquist, Ph.D.
-
Cure
Cholesterol-Lowering Medication May Increase Survival In Breast Cancer
Kevin Nead, M.D.
Prevention Resources
Education
Contact Information
Duncan Family Institute Staff
Jennifer Tektiridis, Ph.D., CPA
Executive Director, Research Planning & Development
Office: 713-792-7891
Email: jtektir@mdanderson.org
Mickie Lubin
Program Director, Office of the Vice President
Office: 713-563-2053
Email: mdlubin@mdanderson.org
Physical Address
Duncan Family Institute for Cancer Prevention and Risk Assessment
Division of Cancer Prevention and Population Sciences
Cancer Prevention Building, 8.3093
1155 Pressler
Houston, TX 77030-3721
Mailing Address
Duncan Family Institute for Cancer Prevention and Risk Assessment
Division of Cancer Prevention and Population Sciences - Unit 1370
PO Box 301439
Houston, TX 77230-1439